Traded Jan 31 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Jan 14, 2026 · Filed Jan 16, 2026
A RH director sold $496K of RH shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$495,880
Shares × reported transaction price
34 days after results of Dec 11, 2025, 76 days before results of Mar 31, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.9% | −0.3% | −1.6% |
| 30 days | −10.4% | −1.3% | −9.1% |
| 90 days | −44.4% | +1.4% | −45.9% |
| 180 days | −18.3% | +9.1% | −27.4% |
Past results only. Not a forecast.
Traded Jan 31 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Traded Jan 31 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Traded Jan 13 · filed 3 days laterNot under a reported trading plan
A RH director sold $440K of RH shares. The filing does not indicate a pre-arranged trading plan.